US judge denies Novo Nordisk bid to halt Eli Lilly weight-loss drug ads

A US judge denied Novo Nordisk's bid to halt Eli Lilly's weight-loss drug ads, which the Danish drugmaker deemed false and misleading, in markets worth tens of billions of dollars a year.

Detected & updated continuously · Source: Nebula